Clinical trials
Dermatomyositis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 4 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Hospital for Sick Children | 3 |
| Peking Union Medical College Hospital | 2 |
| Aarhus University Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Duke University | 1 |
| Federal University of Espirito Santo | 1 |
| Istanbul University - Cerrahpasa | 1 |
| Jiangxi Provincial People's Hopital | 1 |
| Karolinska University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 22 |
| Arthritis, Juvenile | 6 |
| Myositis | 5 |
| Polymyositis | 5 |
| Lupus Erythematosus, Systemic | 4 |
| Rheumatic Diseases | 4 |
| Arthritis, Rheumatoid | 3 |
| Scleroderma, Systemic | 3 |
| Anxiety Disorders | 1 |
| Arthritis | 1 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.